Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer
Approximately 20% patients with non-small cell lung cancer (NSCLC) present with CNS spread at the time of diagnosis and 25–50% are found to have brain metastases (BMs) during the course of the disease. The improvement in the diagnostic tools and screening, as well as the use of new systemic therapie...
Main Authors: | Paola Anna Jablonska, Joaquim Bosch-Barrera, Diego Serrano, Manuel Valiente, Alfonso Calvo, Javier Aristu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/9/2141 |
Similar Items
-
Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases
by: Nitesh Rana, et al.
Published: (2017-11-01) -
The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2021-12-01) -
Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
by: Raees Tonse, et al.
Published: (2021-07-01) -
Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation
by: Laurence Mengue, et al.
Published: (2020-04-01) -
Current status and recent advances in reirradiation of glioblastoma
by: Giuseppe Minniti, et al.
Published: (2021-02-01)